These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 35351536)

  • 1. Gating has a negligible impact on dose delivered in MRI-guided online adaptive radiotherapy of prostate cancer.
    Wahlstedt I; Andratschke N; Behrens CP; Ehrbar S; Gabryś HS; Schüler HG; Guckenberger M; Smith AG; Tanadini-Lang S; Tascón-Vidarte JD; Vogelius IR; van Timmeren JE
    Radiother Oncol; 2022 May; 170():205-212. PubMed ID: 35351536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of intrafractional prostate motion and its dosimetric impact in MRI-guided online adaptive radiotherapy with gating.
    Xiong Y; Rabe M; Nierer L; Kawula M; Corradini S; Belka C; Riboldi M; Landry G; Kurz C
    Strahlenther Onkol; 2023 Jun; 199(6):544-553. PubMed ID: 36151215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning.
    Kim JI; Park JM; Choi CH; An HJ; Kim YJ; Kim JH
    Radiat Oncol; 2019 Aug; 14(1):139. PubMed ID: 31387593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image-guided radiotherapy for prostate cancer with cone beam CT: dosimetric effects of imaging frequency and PTV margin.
    Ariyaratne H; Chesham H; Pettingell J; Alonzi R
    Radiother Oncol; 2016 Oct; 121(1):103-108. PubMed ID: 27576431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time motion-including dose estimation of simulated multi-leaf collimator-tracked magnetic resonance-guided radiotherapy.
    Persson E; Goodwin E; Eiben B; Wetscherek A; Nill S; Oelfke U
    Med Phys; 2024 Mar; 51(3):2221-2229. PubMed ID: 37898109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
    Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
    Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dosimetric error due to uncorrected tumor rotation during real-time adaptive prostate stereotactic body radiation therapy.
    Sengupta C; Skouboe S; Ravkilde T; Poulsen PR; Nguyen DT; Greer PB; Moodie T; Hardcastle N; Hayden AJ; Turner S; Siva S; Tai KH; Martin J; Booth JT; O'Brien R; Keall PJ
    Med Phys; 2023 Jan; 50(1):20-29. PubMed ID: 36354288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic organ motion and dosimetric implications during horizontal patient rotation for prostate radiation therapy.
    Buckley JG; Dowling JA; Sidhom M; Liney GP; Rai R; Metcalfe PE; Holloway LC; Keall PJ
    Med Phys; 2021 Jan; 48(1):397-413. PubMed ID: 33151543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer.
    Tamihardja J; Cirsi S; Kessler P; Razinskas G; Exner F; Richter A; Polat B; Flentje M
    Radiat Oncol; 2021 Oct; 16(1):205. PubMed ID: 34702305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow.
    Mannerberg A; Persson E; Jonsson J; Gustafsson CJ; Gunnlaugsson A; Olsson LE; Ceberg S
    Radiat Oncol; 2020 Jul; 15(1):168. PubMed ID: 32650811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DMLC tracking and gating can improve dose coverage for prostate VMAT.
    Colvill E; Poulsen PR; Booth JT; O'Brien RT; Ng JA; Keall PJ
    Med Phys; 2014 Sep; 41(9):091705. PubMed ID: 25186380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial.
    Nikitas J; Smith LM; Gao Y; Ma TM; Sachdeva A; Yoon SM; Jiang T; Low DA; Ballas LK; Steinberg ML; Cao M; Kishan AU
    Radiother Oncol; 2023 Jun; 183():109631. PubMed ID: 36934894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients.
    Böckelmann F; Putz F; Kallis K; Lettmaier S; Fietkau R; Bert C
    Strahlenther Onkol; 2020 Jul; 196(7):647-656. PubMed ID: 32157345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTV-to-PTV margin assessment for esophageal cancer radiotherapy based on an accumulated dose analysis.
    Boekhoff MR; Defize IL; Borggreve AS; van Hillegersberg R; Kotte ANTJ; Lagendijk JJW; van Lier ALHMW; Ruurda JP; Takahashi N; Mook S; Meijer GJ
    Radiother Oncol; 2021 Aug; 161():16-22. PubMed ID: 33992628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
    Qin A; Sun Y; Liang J; Yan D
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric effects of the prone and supine positions on image guided localized prostate cancer radiotherapy.
    Liu B; Lerma FA; Patel S; Amin P; Feng Y; Yi BY; Yu C
    Radiother Oncol; 2008 Jul; 88(1):67-76. PubMed ID: 18207595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric predictors for genitourinary toxicity in MR-guided stereotactic body radiation therapy (SBRT): Substructure with fraction-wise analysis.
    Pham J; Neilsen BK; Liu H; Cao M; Yang Y; Sheng K; Ma TM; Kishan AU; Ruan D
    Med Phys; 2024 Jan; 51(1):612-621. PubMed ID: 38055353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single institution's dosimetry and IGRT analysis of prostate SBRT.
    Wu QJ; Li T; Yuan L; Yin FF; Lee WR
    Radiat Oncol; 2013 Sep; 8():215. PubMed ID: 24034234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
    Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
    Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
    Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
    Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.